AstraZeneca PLC
AZN
$73.95
$0.861.18%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 8.30B | 7.77B | 7.04B | 6.50B | 6.44B |
| Total Depreciation and Amortization | 5.15B | 5.04B | 5.01B | 5.02B | 4.93B |
| Total Amortization of Deferred Charges | 200.00M | 200.00M | 200.00M | 280.00M | 280.00M |
| Total Other Non-Cash Items | 828.00M | 944.00M | 512.00M | -67.00M | -1.05B |
| Change in Net Operating Assets | -1.08B | -864.00M | -893.00M | -393.00M | 463.00M |
| Cash from Operations | 13.39B | 13.09B | 11.86B | 11.33B | 11.07B |
| Capital Expenditure | -2.21B | -1.94B | -1.92B | -1.74B | -1.64B |
| Sale of Property, Plant, and Equipment | 12.00M | 3.00M | 55.00M | 54.00M | 59.00M |
| Cash Acquisitions | -1.17B | -3.20B | -3.78B | -3.72B | -3.73B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.69B | -1.69B | -2.33B | -2.47B | -2.27B |
| Cash from Investing | -6.06B | -6.82B | -7.98B | -7.88B | -7.58B |
| Total Debt Issued | 756.00M | 1.61B | 6.49B | 7.12B | 7.57B |
| Total Debt Repaid | -2.41B | -5.00B | -5.00B | -5.24B | -4.47B |
| Issuance of Common Stock | 39.00M | 40.00M | 38.00M | 36.00M | 36.00M |
| Repurchase of Common Stock | -570.00M | -567.00M | -81.00M | -81.00M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.94B | -4.94B | -4.63B | -4.63B | -4.46B |
| Other Financing Activities | 126.00M | 128.00M | -817.00M | -817.00M | -887.00M |
| Cash from Financing | -6.99B | -8.73B | -4.00B | -3.62B | -2.21B |
| Foreign Exchange rate Adjustments | 13.00M | -22.00M | -93.00M | -26.00M | -65.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 355.00M | -2.49B | -208.00M | -184.00M | 1.21B |